Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026)

Ascend Wellness Holdings (AAWH) recorded quarterly Liabilities and Shareholders Equity of $872.1 million in Q1 2026, down 3.95% quarter-over-quarter from $907.9 million in Q4 2025, and down 4.87% on a YoY basis from $916.7 million in Q1 2025.

Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $872.1 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 4.87% year-over-year to $872.1 million; the TTM figure through Mar 2026 stood at $3.6 billion (down 1.6% YoY), while the FY2025 annual figure was $907.9 million, up 0.83% from the prior year.
  • Liabilities and Shareholders Equity was $872.1 million for Q1 2026 at Ascend Wellness Holdings, down from $907.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $929.4 million in Q2 2024 to a low of $714.2 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $882.8 million across 5 years, with a median of $900.4 million in 2025.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 48.39% in 2022, then slipped 4.87% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $872.2 million in 2022, then rose by 5.43% to $919.6 million in 2023, then decreased by 2.08% to $900.4 million in 2024, then increased by 0.83% to $907.9 million in 2025, then fell by 3.95% to $872.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $872.1 million (Q1 2026), $907.9 million (Q4 2025), and $900.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Ascend Wellness Holdings - - 44.88 Mn 872.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 872.09 Mn
Dec 31, 2025 907.93 Mn
Sep 30, 2025 900.36 Mn
Jun 30, 2025 903.87 Mn
Mar 31, 2025 916.73 Mn
Dec 31, 2024 900.43 Mn
Sep 30, 2024 895.87 Mn
Jun 30, 2024 929.36 Mn
Mar 31, 2024 921.86 Mn
Dec 31, 2023 919.55 Mn
Sep 30, 2023 907.99 Mn
Jun 30, 2023 899.56 Mn
Mar 31, 2023 870.09 Mn
Dec 31, 2022 872.16 Mn
Sep 30, 2022 847.21 Mn
Jun 30, 2022 828.79 Mn
Mar 31, 2022 714.20 Mn
Dec 31, 2021 723.44 Mn
Sep 30, 2021 716.88 Mn
Jun 30, 2021 578.76 Mn